About Resilience

Strategic Advantages

Resilience specializes in R&D (both CGMP and non-CGMP), Process Development, and Manufacturing of biologics through commercial stage, with full regulatory support. Our ADM facility accommodates development of bulk drug substance with containment up to BSL-3, which is ideal for vaccine and virus manufacturing.  Resilience has a proprietary vaccine delivery technology and a variety of platform expression systems available to our clients.

Expertise in US Government Support

Resilience has been highly successful in obtaining US Government contracts and grants (more than $1B to date) for the advanced development and manufacturing of drugs and biologics of importance to both healthcare and national security. We work with the DoD, BARDA and NIAID to advance medical countermeasures to protect the American warfighter. We work with technology providers to obtain USG funding and to provide CDMO services to advance their products.